Squarepoint’s Acutus Medical Inc AFIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-26,361
Closed -$23.4K 4361
2023
Q2
$23.4K Buy
26,361
+14,284
+118% +$12.1K ﹤0.01% 3485
2023
Q1
$9.11K Buy
+12,077
New +$15.7K ﹤0.01% 3152
2022
Q1
Sell
-12,233
Closed -$42K 3699
2021
Q4
$42K Sell
12,233
-13,228
-52% -$74.5K ﹤0.01% 3046
2021
Q3
$225K Buy
+25,461
New +$335K ﹤0.01% 2415
2021
Q2
Sell
-23,349
Closed -$312K 3823
2021
Q1
$312K Buy
+23,349
New +$526K ﹤0.01% 2367

Other funds holding AFIB

Squarepoint's AFIB Position: Q3 2023 in Review

Squarepoint sold out of Acutus Medical Inc (AFIB) in Q3 2023, closing a stake of 26,361 shares — an estimated $23.4K sold.

Squarepoint first reported a position in AFIB in Q1 2021 and held it in 5 quarters. The position peaked at $312K in Q1 2021. 30 funds tracked by Wall St. Rank hold AFIB as of Q3 2023.

  • Squarepoint reported no remaining Acutus Medical Inc position as of Q3 2023 after selling out during the quarter.
  • Squarepoint sold 26,361 Acutus Medical Inc shares in Q3 2023, an estimated $23.4K.
  • Squarepoint first reported a position in Acutus Medical Inc in Q1 2021 and held it in 5 quarters.
  • Squarepoint's Acutus Medical Inc position peaked at $312K in Q1 2021.
  • 30 funds tracked by Wall St. Rank held Acutus Medical Inc as of Q3 2023.

Based on Squarepoint's 13F filing for Q3 2023, filed 14 Nov 2023.